Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung
Juho Jalkanen, Ville Pettilä, Matti Karvonen, Teppo Huttunen, Jami Mandelin, Markku Jalkanen, Markus Malmberg, Kati Elima, Geoff Bellingan, V. Marco Ranieri, Maija Hollmen, View ORCID ProfileSirpa Jalkanen
doi: https://doi.org/10.1101/2020.04.01.20049700
Juho Jalkanen
1Faron Pharmaceuticals Ltd., Turku, Finland
MDVille Pettilä
2Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
MDMatti Karvonen
1Faron Pharmaceuticals Ltd., Turku, Finland
MDTeppo Huttunen
3Pharma Ltd., Turku, Finland
MScJami Mandelin
1Faron Pharmaceuticals Ltd., Turku, Finland
PhDMarkku Jalkanen
1Faron Pharmaceuticals Ltd., Turku, Finland
PhDMarkus Malmberg
4Heart Center, Turku University Hospital and University of Turku, Turku, Finland
MDKati Elima
5Medicity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Turku, Finland
MDGeoff Bellingan
6Critical Care, University College London Hospitals, NHS Foundation Trust and NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London, London, UK
MDV. Marco Ranieri
7Alma Mater Studiorum – Università di Bologna, Dipartimento di Scienze Mediche e Chirurgiche, Anesthesia and Intensive Care Medicine, Policlinico di Sant’Orsola, Bologna, Italy
MDMaija Hollmen
5Medicity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Turku, Finland
PhDSirpa Jalkanen
5Medicity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Turku, Finland
8Institute of Biomedicine, University of Turku, Turku, Finland
MDData Availability
The data and the novel reagent (anti-CD73 antibody) will be made available to others on reasonable requests to the corresponding author
Posted April 13, 2020.
Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung
Juho Jalkanen, Ville Pettilä, Matti Karvonen, Teppo Huttunen, Jami Mandelin, Markku Jalkanen, Markus Malmberg, Kati Elima, Geoff Bellingan, V. Marco Ranieri, Maija Hollmen, Sirpa Jalkanen
medRxiv 2020.04.01.20049700; doi: https://doi.org/10.1101/2020.04.01.20049700
Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung
Juho Jalkanen, Ville Pettilä, Matti Karvonen, Teppo Huttunen, Jami Mandelin, Markku Jalkanen, Markus Malmberg, Kati Elima, Geoff Bellingan, V. Marco Ranieri, Maija Hollmen, Sirpa Jalkanen
medRxiv 2020.04.01.20049700; doi: https://doi.org/10.1101/2020.04.01.20049700
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)